Human plasma proteins

Key facts

Active substance
Human plasma proteins
Therapeutic area
Haematology-Hemostaseology
Decision number
P/116/2009
PIP number
Human plasma proteins
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
  • Thrombotic thrombocytopenic purpura
  • Treatment of acquired coagulation factor deficiency
  • Hereditary deficiency of clotting factors
Route(s) of administration
Intravenous use
Contact for public enquiries
Octapharma Pharmazeutika Produktionsges.m.b.H
E-mail: medical-affairs@octapharma.com
Country: Austria
Phone: +43 1610321245
Fax: +43 1610329249
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating